Antibody drug conjugates (ADC s) that bind to CD37 protein and variants thereof are described herein. CD37 exhibits a distinct and limited expression patternin normal adult tissue(s) and is aberrantly expressed in the cancers listed in Table I. Consequently the ADC s of the invention in some embodiments provide a therapeutic composition for the treatment of cancer.